Business Context and Reporting Period
This Form 8-K is filed by AmerisourceBergen Corporation (now Cencora, Inc.) on November 5, 2002. The report covers two primary events: the announcement of earnings for the fiscal quarter and fiscal year ended September 30, 2002, and the signing of a definitive agreement to acquire Bridge Medical, Inc.
Key Financial Metrics and Transaction Details
The filing references press releases containing specific earnings data for the fiscal year and quarter ended September 30, 2002, but the text of this 8-K does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
Regarding the acquisition of Bridge Medical, Inc., the financial terms are as follows:
- Initial Consideration: Approximately $27 million payable at closing, primarily in Company common stock.
- Contingent Consideration: Up to $55 million in incentive payments based on Bridge achieving significant earnings targets in calendar years 2003 and 2004.
- Expected Closing: End of calendar year 2002.
Material Changes
The filing does not provide comparative financial data to quantify material changes in revenue or profit versus prior periods. The primary material change disclosed is the strategic expansion into barcode-enabled point-of-care software through the pending acquisition of Bridge Medical, Inc.
Outlook, Risks, and Management Commentary
Management intends to close the Bridge Medical transaction by the end of 2002. The strategic rationale for the acquisition is to reduce medication errors and decrease costs in healthcare facilities. The filing does not contain specific forward-looking guidance on earnings or detailed risk factors beyond the standard contingencies associated with the acquisition closing and the achievement of future earnings targets for incentive payments.
Investor Verification Checklist
- Verify the specific revenue, net income, and earnings per share figures for the fiscal quarter and year ended September 30, 2002, by reviewing the attached Exhibit 99.1 (Press Release).
- Confirm the final closing date of the Bridge Medical, Inc. acquisition and the exact mix of stock versus cash in the initial $27 million payment.
- Review the specific earnings targets defined in the agreement that trigger the up to $55 million in contingent payments.
- Assess the integration plan for Bridge Medical's software into AmerisourceBergen's existing operations.